COVID-19 wrecked 2020. Will 2021 be different?
The year 2020 was turned upside-down by the novel coronavirus. But with the prospect of several vaccines coming online and less stringent restrictions, experts say it's possible 2021 will return to a semblance of normality. With a second COVID-19 wave currently battering Europe, the United ...
Why the U.K. approved a COVID-19 vaccine first
Doses of the Pfizer-BioNTech vaccine will be injected starting next week, the government said.
China gave COVID-19 vaccine candidate to North Korea's Kim, U.S. analyst says
China has provided North Korean leader Kim Jong Un and his family with an experimental coronavirus vaccine, a U.S. analyst said on Tuesday, citing two unidentified Japanese intelligence sources. Harry Kazianis, a North Korea expert at the Center for the National Interest think tank in ...
Moderna to seek U.S. and EU clearance for COVID-19 vaccine
The move came after a new analysis showed the vaccine was highly effective in preventing COVID-19 with no serious safety problems.
Airlines face ‘mission of the century’ in shipping vaccines
Laid low by a COVID-19 outbreak that’s decimated passenger demand, airlines will be the workhorses of the attempt to eradicate it, hauling billions of vials to every corner of the globe.
U.K. poised to be first to approve Pfizer-BioNTech COVID-19 vaccine
The U.K. is poised to become the first country to approve Pfizer Inc. and BioNTech SE’s COVID-19 vaccine, ahead of a long line of countries waiting for protection from the coronavirus. Clearance is possible as soon as early next week, according to a person familiar ...
COVID-19 vaccine delays undermine Indonesia’s path to immunity
With new cases topping 30,000 a week, Indonesia faces an urgent logistical challenge to ensure that vaccines are distributed across a country spanning thousands of kilometers.
COVID-19 vaccine rush in China raises fears of booming black market
Chinese vaccine-makers have also yet to release any public data on the efficacy of their shots, making it difficult to tell how successful their efforts have been.
AstraZeneca considers extra global vaccine trial as questions mount
Many low- and middle-income countries are relying on the firm, which has pledged to sell its vaccine at cost during the pandemic.
After admitting error, AstraZeneca faces hard questions on vaccine
Scientists said a series of irregularities and omissions in the way AstraZeneca initially disclosed the data have eroded their confidence in the reliability of the results.
After a year-long sprint, COVID-19 vaccines are finally at hand
Less than a year after an unknown coronavirus that has claimed 1.4 million lives began spreading across the globe, a number of highly promising COVID-19 vaccines are on the cusp of release. Health authorities could give a green light for emergency use within weeks, which ...
The WHO defined an infodemic as an overabundance of information, both online and offline, including "deliberate attempts to disseminate wrong information."
